1、邮储银行最近3年的股息率分别为：5.58%，6.00%，4.61% 2、公司属于国有企业。公司的最终控制人为中国邮政集团有限公司。 来源：新浪证券-红岸工作室 9月11日，邮储银行涨0.32%，成交额8.54亿元，换手率0.20%，总市值7529.96亿元。 异动分析 高股息精选+国企改革 该股筹码平均交易成本为5.06元，近期该股获筹码青睐，且集中度渐增；目前股价靠近压力位6.40，谨 防压力位处回调，若突破压力位则可能会开启一波上涨行情。 公司简介 (免责声明：分析内容来源于互联网，不构成投资建议，请投资者根据不同行情独立判断) 资金分析 今日主力净流入-8774.70万，占比0.1%，行业排名4/6，连续2日被主力资金减仓；所属行业主力净流 入-8.20亿，当前无连续增减仓现象，主力趋势不明显。 区间今日近3日近5日近10日近20日主力净流入-8774.70万-8805.36万-1.54亿4.31亿9.09亿 主力持仓 主力没有控盘，筹码分布非常分散，主力成交额3.33亿，占总成交额的5.92%。 技术面：筹码平均交易成本为5.06元 资料显示，中国邮政储蓄银行股份有限公司位于中国北京市西城区金融大 ...

9月10日，渝农商行盘中上涨2.14%，截至13:50，报6.68元/股，成交5.44亿元，换手率0.93%，总市值 758.65亿元。 资金流向方面，主力资金净流出30.77万元，特大单买入4219.27万元，占比7.75%，卖出3642.71万元， 占比6.69%；大单买入1.22亿元，占比22.43%，卖出1.28亿元，占比23.55%。 渝农商行今年以来股价涨16.28%，近5个交易日涨1.98%，近20日跌0.74%，近60日跌6.44%。 资料显示，重庆农村商业银行股份有限公司位于重庆市江北区金沙门路36号,香港铜锣湾希慎道33号利 园1期19楼1920室，成立日期2008年6月27日，上市日期2019年10月29日，公司主营业务涉及重庆农村商 业银行主要从事提供银行服务及相关金融服务业务。该公司通过三个业务部门运营。公司银行业务部从 事向公司类客户、政府机构及金融机构提供金融产品和服务业务。个人银行业务部从事向个人客户提供 金融产品和服务业务。金融市场业务部从事货币市场交易、回购交易以及为其本身或代表客户进行债务 工具投资业务。主营业务收入构成为：零售银行业务41.93%，公司银行业务30.58 ...

Core Viewpoint - Guangshen Railway's stock price has shown a positive trend with a year-to-date increase of 1.79% and significant gains over the past 20 and 60 days, indicating strong market performance and investor interest [2]. Financial Performance - For the first half of 2025, Guangshen Railway achieved operating revenue of 13.969 billion yuan, representing a year-on-year growth of 8.08%, while net profit attributable to shareholders reached 1.109 billion yuan, up 21.55% [2]. - The company has distributed a total of 8.642 billion yuan in dividends since its A-share listing, with 992 million yuan distributed over the past three years [3]. Shareholder Structure - As of June 30, 2025, the number of shareholders for Guangshen Railway was 158,200, a decrease of 1.05% from the previous period [2]. - The top ten circulating shareholders include major funds, with notable changes in holdings among several funds, indicating active management and investment strategies [3]. Stock Market Activity - On September 8, Guangshen Railway's stock rose by 2.09%, with a trading volume of approximately 98.86 million yuan and a market capitalization of 24.226 billion yuan [1]. - The stock has seen a turnover rate of 0.52%, with net outflows of 6.8287 million yuan from main funds, suggesting mixed investor sentiment [1].

Group 1 - The core viewpoint of the news is that Datang Power's stock has shown significant growth this year, with a 30.56% increase, and the company has reported a substantial rise in net profit for the first half of 2025 [1][2] - As of September 5, Datang Power's stock price was 3.64 CNY per share, with a market capitalization of 67.364 billion CNY and a trading volume of 468 million CNY [1] - The company's main business revenue composition includes 87.14% from electricity sales, 6.41% from other products, 5.09% from heat sales, and 1.36% from other sources [1] Group 2 - For the first half of 2025, Datang Power achieved operating revenue of 57.193 billion CNY, a year-on-year decrease of 1.92%, while net profit attributable to shareholders increased by 47.33% to 4.579 billion CNY [2] - The company has distributed a total of 22.460 billion CNY in dividends since its A-share listing, with 1.825 billion CNY distributed in the last three years [3] - As of June 30, 2025, the number of shareholders decreased by 7.63% to 161,600, with an average of 0 circulating shares per shareholder [2]

Company Overview - Rongchang Biopharmaceuticals is an innovative biopharmaceutical company focused on antibody-drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies, and bispecific antibodies [2] - The company aims to discover, develop, and commercialize innovative and best-in-class biopharmaceuticals to address unmet clinical needs in autoimmune diseases, oncology, and ophthalmology [2] - Main business revenue composition: 99.46% from product sales, 0.38% from material sales, and 0.16% from leasing services [2] Financial Performance - As of June 30, 2025, Rongchang Biopharmaceuticals reported a revenue of 1.098 billion yuan, a year-on-year increase of 48.02% [3] - The net profit attributable to shareholders was -450 million yuan, reflecting a year-on-year growth of 42.40% [3] Shareholder and Market Activity - As of June 30, 2025, the number of shareholders increased to 12,900, up by 90.69%, while the average circulating shares per person decreased by 47.56% [3] - The stock price of Rongchang Biopharmaceuticals has increased by 187.28% year-to-date, with a recent decline of 4.82% over the last five trading days [1] - The company has appeared on the "Dragon and Tiger List" four times this year, with the most recent appearance on June 26, where it recorded a net buy of -137 million yuan [1] Institutional Holdings - As of June 30, 2025, notable new institutional shareholders include Hong Kong Central Clearing Limited, Wanjiayouxuan, and ICBC Frontier Medical Stock A [4] - The top ten circulating shareholders include various funds, with some showing significant changes in holdings compared to the previous period [4]

Core Viewpoint - 弘业期货 has shown a significant increase in stock price and trading volume, indicating potential investor interest and market activity [1] Company Overview - 弘业期货股份有限公司 primarily engages in commodity futures brokerage, financial futures brokerage, futures investment consulting, asset management, fund sales, and financial asset investment [2][7] - The company is the first A+H share listed company in the futures industry [2] - As of June 30, 2025, 弘业期货 reported a total revenue of 0.00 yuan and a net profit of -3.61 million yuan, a year-on-year decrease of 128.17% [7] Ownership and Control - 弘业期货 is a state-owned enterprise, ultimately controlled by the Jiangsu Provincial Government State-owned Assets Supervision and Administration Commission [3] Financial Performance - The company has a market capitalization of 11.87 billion yuan and a trading volume of 298 million yuan with a turnover rate of 3.34% [1] - The average trading cost of the stock is 12.84 yuan, with the current stock price near a resistance level of 11.84 yuan [6] Shareholder Information - As of June 30, 2025, the number of shareholders increased by 43.72% to 62,600 [7] - The top ten circulating shareholders include Hong Kong Central Clearing Limited and Southern CSI 1000 ETF, with notable increases in their holdings [8]

Core Viewpoint - Longyuan Power experienced a decline of 1.54% on September 3, with a trading volume of 112 million yuan and a total market capitalization of 139.275 billion yuan [1] Company Overview - Longyuan Power Group Co., Ltd. is primarily engaged in wind and solar power generation, with its main products being electricity and heat [2][5] - The company was established on January 27, 1993, and was listed on January 24, 2022 [5] - The company's revenue composition is 99.22% from electricity products and 0.78% from other sources [5] Recent Developments - Longyuan Power has an operational wind power capacity of 1,590,800 kW in Xinjiang [2] - The company signed a framework agreement with the People's Government of Tieli City, Heilongjiang Province, for a 3.53 million kW renewable energy project [2] - A joint venture, Longyuan Shengda, will be established with Xinong Chuang Investment Development Co., Ltd. to develop a 3 million kW pumped storage project [2] Financial Performance - For the first half of 2025, Longyuan Power reported a revenue of 15.657 billion yuan, a year-on-year decrease of 17.09%, and a net profit attributable to shareholders of 3.375 billion yuan, down 11.82% year-on-year [6] - The company has distributed a total of 5.978 billion yuan in dividends since its A-share listing, with 4.746 billion yuan distributed in the last three years [7] Shareholder Structure - As of June 30, 2025, the number of shareholders increased by 1.18% to 41,000 [6] - Major shareholders include Hong Kong Central Clearing Limited and various ETFs, with notable increases in holdings [8]

Company Overview - Shenwan Hongyuan Group Co., Ltd. is located in Urumqi, Xinjiang, and was established on September 16, 1996. It was listed on January 26, 2015. The company primarily engages in financial investment and equity investment [1] - The main business revenue composition includes: Institutional Services and Trading (54.28%), Personal Finance (31.81%), and Corporate Finance (9.73%), with Investment Banking contributing 5.73% and Investment Management 4.18% [1] Financial Performance - As of June 30, 2025, Shenwan Hongyuan reported a net profit attributable to shareholders of 4.284 billion yuan, representing a year-on-year growth of 101.32% [2] - The company has cumulatively distributed cash dividends of 17.230 billion yuan since its A-share listing, with 3.731 billion yuan distributed over the past three years [3] Stock Market Activity - On September 3, Shenwan Hongyuan's stock price decreased by 2.04%, closing at 5.27 yuan per share, with a trading volume of 478 million yuan and a turnover rate of 0.40%. The total market capitalization is 131.961 billion yuan [1] - Year-to-date, the stock price has declined by 0.64%, with a 3.83% drop over the last five trading days and a 0.45% drop over the last 20 days. However, there has been an 8.57% increase over the last 60 days [1] Shareholder Information - As of June 30, 2025, the number of shareholders is 227,300, a decrease of 3.16% from the previous period. The average number of circulating shares per person is 99,180, an increase of 3.26% [2] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 388 million shares, a decrease of 15.6318 million shares compared to the previous period [3]

Core Viewpoint - CITIC Securities experienced a decline in stock price by 2.01% on September 3, 2023, with a trading volume of 2.485 billion yuan and a market capitalization of 446.988 billion yuan [1] Group 1: Stock Performance - Year-to-date, CITIC Securities' stock price has increased by 4.40%, with a recent 5-day decline of 2.36%, a 20-day increase of 4.43%, and a 60-day increase of 15.56% [2] - As of June 30, 2023, the number of shareholders decreased by 11.13% to 658,700, while the average circulating shares per person increased by 12.53% to 18,490 shares [2] Group 2: Financial Performance - For the first half of 2025, CITIC Securities reported a net profit attributable to shareholders of 13.719 billion yuan, representing a year-on-year growth of 29.80% [2] - The company has cumulatively distributed dividends of 88.704 billion yuan since its A-share listing, with 22.009 billion yuan distributed over the past three years [3] Group 3: Shareholding Structure - As of June 30, 2023, the largest circulating shareholder is Hong Kong Central Clearing Limited, holding 584 million shares, an increase of 28.5704 million shares from the previous period [3] - The Huaxia SSE 50 ETF and Huatai-PB CSI 300 ETF are among the top ten circulating shareholders, with holdings of 191 million shares and 174 million shares, respectively [3]

Core Viewpoint - Xinhua Insurance's stock price has shown a year-to-date increase of 33.72%, with a recent decline of 3.35% over the past 20 days, indicating volatility in its performance [1]. Financial Performance - As of June 30, 2025, Xinhua Insurance reported a net profit of 14.799 billion yuan, reflecting a year-on-year growth of 33.53% [2]. - The company has cumulatively distributed dividends amounting to 35.939 billion yuan since its A-share listing, with 13.913 billion yuan distributed over the past three years [3]. Shareholder Information - The number of shareholders for Xinhua Insurance decreased by 15.88% to 61,000 as of June 30, 2025, while the average number of circulating shares per person increased by 18.96% to 34,325 shares [2]. - As of June 30, 2025, Hong Kong Central Clearing Limited is the fourth-largest circulating shareholder, holding 60.5095 million shares, an increase of 6.6977 million shares from the previous period [3]. Stock Market Activity - On September 3, Xinhua Insurance's stock price fell by 2.03% to 63.80 yuan per share, with a trading volume of 695 million yuan and a turnover rate of 0.51% [1]. - The net outflow of main funds was 20.9114 million yuan, with large orders accounting for 25.85% of purchases and 27.85% of sales [1].